Table 9.
Allocation of antivirals for Scenario 1.3
Mild | Moderate | Critical | Total antiviral | |
---|---|---|---|---|
No antiviral | 700 | 0 | 0 | NA |
Antiviral A | 50 | 0 | 50 | 100 |
Antiviral B | 50 | 150 | 0 | 200 |
Total infected symptomatic | 800 | 150 | 50 |
Allocation of antivirals for Scenario 1.3
Mild | Moderate | Critical | Total antiviral | |
---|---|---|---|---|
No antiviral | 700 | 0 | 0 | NA |
Antiviral A | 50 | 0 | 50 | 100 |
Antiviral B | 50 | 150 | 0 | 200 |
Total infected symptomatic | 800 | 150 | 50 |